These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 7974500)

  • 1. In vitro effects of hydroquinone, benzoquinone, and doxorubicin on mouse and human bone marrow cells at physiological oxygen partial pressure.
    Colinas RJ; Burkart PT; Lawrence DA
    Toxicol Appl Pharmacol; 1994 Nov; 129(1):95-102. PubMed ID: 7974500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of interleukin-1 beta and tumor necrosis factor-alpha on in vitro colony formation by human hematopoietic progenitor cells exposed to doxorubicin or hydroquinone.
    Colinas RJ; Burkart PT; Lawrence DA
    Exp Hematol; 1995 Nov; 23(12):1247-55. PubMed ID: 7589278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of benzene metabolites on differentiation of bone marrow progenitor cells.
    Irons RD; Stillman WS
    Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1247-50. PubMed ID: 9118900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroquinone modulates the GM-CSF signaling pathway in TF-1 cells.
    Zheng JH; Pyatt DW; Gross SA; Le AT; Kerzic PJ; Irons RD
    Leukemia; 2004 Jul; 18(7):1296-304. PubMed ID: 15129224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. I. Effects of in vitro culturing with IL-3 and GM-CSF on human and mouse bone marrow cells purged with mafosfamide (ASTA-Z).
    Slavin S; Mumcuoglu M; Landesberg-Weisz A; Kedar E
    Bone Marrow Transplant; 1989 Sep; 4(5):459-64. PubMed ID: 2676042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation of hydroquinone by copper: chemical mechanism and biological effects.
    Li Y; Trush MA
    Arch Biochem Biophys; 1993 Jan; 300(1):346-55. PubMed ID: 8424668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of synergy between granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in colony formation from human marrow cells in vitro.
    Hara H; Namiki M
    Exp Hematol; 1989 Aug; 17(7):816-21. PubMed ID: 2473914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
    Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
    Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between different high proliferative potential colony-forming cells in mouse bone marrow.
    Kriegler AB; Verschoor SM; Bernardo D; Bertoncello I
    Exp Hematol; 1994 May; 22(5):432-40. PubMed ID: 7513652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lineage-related cytotoxicity and clonogenic profile of 1,4-benzoquinone-exposed hematopoietic stem and progenitor cells.
    Chow PW; Abdul Hamid Z; Chan KM; Inayat-Hussain SH; Rajab NF
    Toxicol Appl Pharmacol; 2015 Apr; 284(1):8-15. PubMed ID: 25645895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL-3), IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF) in serum-supplemented and serum-free medium.
    De Bruyn C; Delforge A; Bron D; Ley P; de Hemptinne D; Stryckmans P
    Stem Cells; 1994 Nov; 12(6):616-25. PubMed ID: 7533580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythroid progenitor cells that survive benzene exposure exhibit greater resistance to the toxic benzene metabolites benzoquinone and hydroquinone.
    Neun DJ; Penn A; Snyder CA
    Arch Toxicol; 1994; 68(9):535-40. PubMed ID: 7998818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
    Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic action of the benzene metabolite hydroquinone on myelopoietic stimulating activity of granulocyte/macrophage colony-stimulating factor in vitro.
    Irons RD; Stillman WS; Colagiovanni DB; Henry VA
    Proc Natl Acad Sci U S A; 1992 May; 89(9):3691-5. PubMed ID: 1570288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How benzene and its metabolites affect human marrow derived mesenchymal stem cells.
    Zolghadr F; Sadeghizadeh M; Amirizadeh N; Hosseinkhani S; Nazem S
    Toxicol Lett; 2012 Oct; 214(2):145-53. PubMed ID: 22960397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AM5, a protein-associated polysaccharide, stimulates hematopoiesis and modulates the expression of endogenous hematopoietic growth factors in murine long-term bone marrow cultures.
    Güenechea G; Bueren JA; Maganto G; Tuduri P; Guerrero A; Pivel JP; Real A
    Stem Cells; 1995 Mar; 13(2):175-85. PubMed ID: 7540471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased granulopoiesis after sequential administration of transforming growth factor-beta 1 and granulocyte-macrophage colony-stimulating factor.
    Hestdal K; Jacobsen SE; Ruscetti FW; Longo DL; Boone TC; Keller JR
    Exp Hematol; 1993 Jun; 21(6):799-805. PubMed ID: 8500577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.